
The SAHARA token experienced a dramatic decline of approximately 55% on June 9, with its price dropping near an all-time low. The project’s team responded swiftly, denying any security breaches or insider selling, and attributed a major token movement to a planned liquidity deposit for a cross-chain bridge.
Trading volumes surged past $300 million as the token fell from heights of $0.03957 to lows of $0.01452. At press time, SAHARA was trading around $0.01718, still under severe pressure. The team emphasized that all contracts and products remain secure, while an internal investigation into the sell-off is ongoing.
In a statement, Sahara AI clarified that a transfer of 600 million SAHARA tokens, previously suspected as a dump, was actually a pre-scheduled deposit into a Chainlink CCIP bridge contract to facilitate liquidity between Ethereum and BNB Chain. An additional 150 million tokens are also scheduled for the same purpose. The address cited matches a verified LockReleaseTokenPool contract on Etherscan, created by the Sahara AI deployer, supporting the team’s explanation. However, the on-chain data does not pinpoint the exact catalyst for the selling pressure.
The market cap fell to approximately $58.5 million, with the token trading nearly 90% below its all-time high of around $0.1605 from July 2025. Trading volume spiked over 340% compared to the previous day, though it remains unclear whether the move was driven by a single large holder, multiple accounts, liquidations, or broader market sentiment. The project’s maximum supply is 10 billion tokens, with roughly 3.4 billion currently in circulation. A planned unlock of about 1.03 billion SAHARA on June 26 has been noted, but no evidence links it to the recent decline.
Sahara AI had previously raised $43 million in a 2024 funding round led by Binance Labs, Pantera Capital, and Polychain Capital. The token has a history of volatility, having dropped 60% after its exchange listings in June 2025. The team has promised to release further updates as soon as confirmed information is available.








